Trial Profile
The additional effect of the respiratory rehabilitation to the COPD patient who did additional medical treatment of budesonide / formoterol at tiotropium
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 03 Sep 2013 New trial record